When all else has failed, and the patient does not meet admission criteria, where do patients go? Obs, of course! I view it as a valuable tool to augment my ED armamentarium. Specifically, for instances like, say, gastroparesis or cyclic vomiting.
This randomized, double-blind, placebo-controlled trial was performed at two urban hospitals looking at patients with a previous diagnosis of gastroparesis comparing conventional therapy + placeo to conventional therapy + 5mg of IV haloperidol. They looked at pain severity and nausea every 15 minutes for 1 hour. Secondary outcomes were disposition status (hospital admission or discharge), ED length of stay, and nausea resolution at 1 hour. Sadly, they only looked at 33 patients total over a two year study period.
While the two groups were similar in terms of the conventional therapy received, in the haloperidol group, disposition was made sooner and more patients were discharged home, with a significant reduction in pain at one hour (on a scale of 0-10, a mean improvement of 5.37 vs 1.11 in favor haloperidol), as well a reduction in nausea at one hour (scale of 0-5, improvement of 2.7 vs 0.72 in favor of haloperidol). Fewer patients were admitted (26.7% vs 72.2%) who received haloperidol, with median length of stay shorter for haloperidol (4.8 hrs vs 9 hrs). Surprisingly, patients in the haloperidol group experienced no adverse events, including QT prolongation and dystonic reactions. This is probably due to small sample size.
This does not address haloperidol as sole treatment, and at only a few dozen patients in this study, certainly does not solidify haloperidol’s use as first line. However, it does add to the pile of data showing haloperidol as safe and efficacious in these patients. As an aside, if your hospital is anything like mine, you can not give haloperidol IV, so I’ve trialed 5-10mg IM. Over the last 4-5 years, I’ve become fond of IM haloperidol for refractory vomiting, and (anecdotally) I’ve used it dozens of times with high rates of success.
So yes, better analgesia, decreased nausea, fewer admissions, and decreased LoS with haloperidol. Pretty much everything you want. I just wish a broader study in non-specific abdominal pain with vomiting would compare haloperidol as singular treatment and compare it to standard care.
Look, there are some patients who are vomiting so profusely that they seemingly require an exorcism. For those patients, I think adding a bit of haloperidol for symptomatic relief does not have much downside, I just wouldnt go mixing multiple QT prolonging agents at once.
So, I ask, whats downside?